Dijon
Dijon
Dijon, France, France7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Withdrawal of Dupilumab in Severe Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 4 | 2026-10-08 | NCT06818019 | |
| Targeted Temperature Management at 33°C Versus Controlled Normothermia for In-hospital Cardiac Arrest | cardiac arrest, cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2026-09-17 | NCT07086703 | |
| A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 3 | 2026-08-12 | NCT06865417 | |
| Treatment Resistant Depression and Vagus Nerve Stimulation | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-06-23 | NCT05952674 | |
| Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria. | Embolism, Embolism and Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-04-23 | NCT07315347 | |
| Optimization of the Parameters of Vagal Nerve Stimulation | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Active, not recruiting | Not applicable | 2026-02-10 | NCT04693221 | |
| Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not applicable | 2025-04-10 | NCT05945524 |